Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline 0 13.05.2024 14:11 Fiercebiotech.com Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline ntaylor Mon, 05/13/2024 - 07:11
